Perrigo to Release First Quarter 2026 Financial Results on May 6, 2026

Rhea-AI Summary

Perrigo (NYSE: PRGO) will release first quarter 2026 financial results on May 6, 2026 and host an earnings conference call at 8:30 A.M. ET. The call will stream live via the investor relations webcast and is accessible by phone; a taped replay will be available through May 13, 2026.

Investor contacts and replay/access details are provided for shareholders and analysts.

AI-generated analysis. Not financial advice.

News Market Reaction – PRGO

-0.21%

1 alert

-0.21% News Effect

On the day this news was published, PRGO declined 0.21%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Earnings release date: May 6, 2026 Conference call time: 8:30 A.M. (EST) Q4 2025 net sales: $1.11B +5 more

8 metrics

Earnings release date May 6, 2026 Scheduled Q1 2026 financial results announcement

Conference call time 8:30 A.M. (EST) Start time for Q1 2026 earnings conference call

Q4 2025 net sales $1.11B Fourth quarter 2025, down 2.5% year over year

FY2025 net sales $4.25B Full-year 2025 net sales, down 2.8%

Goodwill impairment $1.3B Recorded in Q4 2025

FY2025 adjusted EPS $2.75 Full-year 2025 adjusted EPS, up 7%

Current share price $11.73 Pre-news close vs 52-week range $9.23–$28.44

52-week high $28.435 Upper end of 52-week trading range before this news

Market Reality Check

Price: $10.61 Vol: Volume 2,105,904 is below...

low vol

$10.61 Last Close

Volume Volume 2,105,904 is below the 20-day average of 3,122,811 (relative volume 0.67x). low

Technical Shares at $11.73 are trading below the 200-day moving average of $17.48 and well below the 52-week high of $28.44.

Peers on Argus

PRGO fell 2.57% with several peers also lower: PBH -1.88%, AMRX -1.77%, INDV -0....

PRGO fell 2.57% with several peers also lower: PBH -1.88%, AMRX -1.77%, INDV -0.71%, BHC -2.72%, HCM -4.74%. Scanner data does not flag this as a coordinated sector momentum move.

Previous Earnings date Reports

1 past event · Latest: Feb 13 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	Move	Catalyst
Feb 13	Earnings date notice	Neutral	+1.1%	Set date and details for Q4 and FY2025 earnings release and call.

Pattern Detected

Previous earnings-date scheduling news prompted a modestly positive move after the announcement.

Recent Company History

Over the last several months, Perrigo has focused on its consumer health strategy while managing softer top-line trends. Q3 and Q4 2025 results showed net sales declines but growing adjusted EPS and significant cost savings, alongside a large goodwill impairment. The company has updated its FY2026 outlook and maintained its dividend. Today’s notice of the Q1 2026 earnings release continues a regular cadence of communications around quarterly results and investor updates.

Historical Comparison

+1.1% avg move · In the past 6 months, PRGO issued one similar earnings-date notice, which saw an average move of 1.1...

earnings date

+1.1%

Average Historical Move earnings date

In the past 6 months, PRGO issued one similar earnings-date notice, which saw an average move of 1.11%, suggesting historically modest reactions to this type of news.

The company maintains a consistent pattern of preannouncing dates and access details for quarterly earnings calls, supporting regular engagement with investors.

Market Pulse Summary

This announcement sets the timetable for Perrigo’s Q1 2026 results and earnings call on May 6, 2026,...

Analysis

This announcement sets the timetable for Perrigo’s Q1 2026 results and earnings call on May 6, 2026, continuing its regular disclosure cadence. In the months leading up to this, investors saw declining 2025 net sales, a significant goodwill impairment, but higher adjusted EPS and new FY2026 guidance. As the call approaches, attention will likely focus on revenue trends, execution on cost programs, and any updates to the 2026 outlook.

Key Terms

over-the-counter (otc), forward-looking statements, form 10-k

3 terms

over-the-counter (otc) medical

"As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers..."

Over-the-counter (OTC) describes stocks and other securities traded directly between buyers and sellers outside formal exchanges, using brokers, dealers, or electronic networks. For investors it matters because OTC trading often means lower transparency, fewer rules and thinner trading volume—like buying at a small flea market instead of a big supermarket—so prices can swing more and the risk of not being able to sell quickly is higher.

forward-looking statements regulatory

"This press release includes, and the matters discussed... will include certain "forward-looking statements"..."

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

form 10-k regulatory

"...including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2025."

A Form 10-K is a comprehensive report that publicly traded companies are required to file annually with regulators. It provides a detailed overview of a company's financial health, operations, and risks, similar to a detailed health report. Investors use this information to assess the company's performance and make informed decisions about buying or selling its stock.

AI-generated analysis. Not financial advice.

DUBLIN, April 22, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer health products, today announced that it plans to issue its first quarter 2026 financial results on Wednesday, May 6, 2026, and host a conference call beginning at 8:30 A.M. (EST).

The earnings conference call will be available live via webcast in the investor relations section of the Perrigo website at http://perrigo.investorroom.com/events-webcasts or by phone at 800-836-8184, International 646-357-8785, and reference ID # 82404. A taped replay of the call will be available beginning at approximately 12:00 P.M. (EST) Wednesday, May 6, until midnight Wednesday, May 13, 2026. To listen to the replay, dial 888-660-6345, International 646-517-4150, and use access code 82404#.

About Perrigo

Perrigo Company plc is a leading pure-play consumer health company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers.

Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill^®, Mederma^®, Compeed^®, EllaOne^®, and Jungle Formula^®.

For more information, visit www.perrigo.com.

Forward-Looking Statements

This press release includes, and the matters discussed in Perrigo's upcoming earnings release will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2025.

Perrigo Contact

Eric Jacobson, Vice President, Global Investor Relations
(616) 886-0375, eric.jacobson@perrigo.com

Nick Gallagher, Associate Director, Global Investor Relations
(269) 686-3238, nicholas.gallagher@perrigo.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/perrigo-to-release-first-quarter-2026-financial-results-on-may-6-2026-302749501.html

SOURCE Perrigo Company plc

FAQ

When will Perrigo (PRGO) report Q1 2026 results and hold the conference call?

Perrigo will report Q1 2026 results on May 6, 2026 with a conference call at 8:30 A.M. ET. According to Perrigo, the call will be available via webcast and phone for investors and analysts to listen live.

How can investors access the Perrigo (PRGO) May 6, 2026 earnings call webcast?

Investors can access the webcast via Perrigo's investor relations events page. According to Perrigo, the live stream will be hosted at the company's investor relations site with dial‑in options provided for phone participants.

What are the phone dial‑in and replay details for Perrigo (PRGO) Q1 2026 earnings call?

Dial‑in numbers for the live call include 800‑836‑8184 (U.S.) and 646‑357‑8785 (international), reference ID 82404. According to Perrigo, a taped replay will be available from noon May 6 until midnight May 13, 2026.

Where can I find Perrigo (PRGO) investor materials and SEC filings referenced for Q1 2026?

Investor materials and SEC filings are available on Perrigo's investor relations and SEC filings pages. According to Perrigo, interested persons should consult the company's investor site for the earnings release, Form 10‑Q, and related disclosures.

Who are the investor relations contacts for Perrigo (PRGO) regarding the May 6, 2026 results?

Perrigo lists Eric Jacobson and Nick Gallagher as investor relations contacts with phone numbers and emails. According to Perrigo, investors may reach out to those contacts for questions about the Q1 2026 results and the conference call logistics.